Periodic Reporting for period 4 - VSV-EBOVAC (Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842)

Ebola virus disease (EVD) is a severe often fatal haemorrhagic fever with an average case fatality rate that ranges from 50 to 90%. Currently no licensed therapies or vaccines exist for EVD and correlates of protection are not yet fully established. The overall objective of...